
1. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017
Oct;60(10):1075-1082. doi: 10.1007/s00103-017-2606-x.

[Costs associated with multiresistant bacteria in neurorehabilitation].

[Article in German]

Roukens R(1), Lauster F(2), Bara M(3), Eifert B(4), Willemsen D(5), Randall T(6),
Herzog J(7), Wendt C(8), Schmidt-Wilcke T(1)(9), Knecht S(10)(11)(12).

Author information: 
(1)Mauritius Therapieklinik, Heinrich-Heine Universität Düsseldorf, Strümper
Straße 111, 40670, Meerbusch, Deutschland.
(2)Schön Klinik, Bad Aibling, Deutschland.
(3)Klinik und Rehabilitationszentrum Lippoldsberg, Wahlsberg, Deutschland.
(4)SRH Fachkrankenhaus, Neresheim, Deutschland.
(5)DRK-Krankenhaus, Middelburg, Deutschland.
(6)Asklepios Kliniken, Schildautal-Seesen, Deutschland.
(7)Schön Klinik, München-Schwabing, Deutschland.
(8)Labor Dr. Limbach und Kollegen, Heidelberg, Deutschland.
(9)Klinische Neurowissenschaften und Medizinische Psychologie,
Universitätsklinikum Düsseldorf, Düsseldorf, Deutschland.
(10)Mauritius Therapieklinik, Heinrich-Heine Universität Düsseldorf, Strümper
Straße 111, 40670, Meerbusch, Deutschland. Stefan.Knecht@stmtk.de.
(11)Klinische Neurowissenschaften und Medizinische Psychologie,
Universitätsklinikum Düsseldorf, Düsseldorf, Deutschland. Stefan.Knecht@stmtk.de.
(12)Hygiene-Kommission der Deutschen Gesellschaft für Neurorehabilitation (DGNR),
Meerbusch, Deutschland. Stefan.Knecht@stmtk.de.

BACKGROUND AND OBJECTIVES: The number of patients with multiresistant bacteria
(MRB) in rehabilitation facilities is increasing. The increasing costs of
hygienic isolation measures reduce resources available for core rehabilitation
services. In addition to the existing lack of care, patients with MRB are at
further risk of being given lower priority for admission to rehabilitation
facilities. Therefore, the Hygiene Commission of the German Society for
Neurorehabilitation (DGNR) attempted to quantify the overall risk for
deterioration of rehabilitation care due to the financial burden of MRB.
MATERIALS AND METHODS: To analyze the added costs associated with the
rehabilitation of patients with MBR, the DGNR Hygiene Commission identified
criteria for a cost assessment. Direct (consumables, personnel and miscellaneous 
costs) and indirect costs of loss of opportunity were evaluated in seven
neurorehabilitation centers in different states across Germany.
RESULTS: On average, hygienic isolation measures amounted to direct costs of
144 € per day (47 € consumables, 92 € personnel, 5 € for other costs such as
extra transportation expenditure) and indirect costs of 274 €, totaling 418 € per
patient with MRB per day. Given that approximately 10% of patients had MRB, the
added costs of hygienic isolation measures equaled about one tenth of the overall
budget of a rehabilitation center and can be expected to rise with the increasing
numbers of patients with MRB.
CONCLUSIONS: Admission of patients carrying MRB to neurorehabilitation centers
triggers added costs that critically diminish the overall capacity for centers to
provide their core rehabilitation services.

DOI: 10.1007/s00103-017-2606-x 
PMID: 28812106  [Indexed for MEDLINE]

